This can include increased energy levels, improved mood, and a greater sense of well-being as they achieve their health goals
Weeks 9-12: 1.0 mg once weekly
A clinician may watch for mood changes, anxiety changes, sleep disruption, bruising or bleeding, sodium problems, manic symptoms, and adverse effects that affect daily life
Boxed Warning: Risk of Thyroid C-Cell Tumors In rodent studies, semaglutide caused thyroid C-cell tumors
The related Retatrutide Benefits page explores that topic in more detail
Other weight-loss drugs are currently in development or regulatory approval stages, including: Once-daily GLP-1 pill orforglipron (Eli Lilly), which, when taken alongside a healthy diet and exercise, resulted in a 7.5% weight loss over 72 weeks on the 6mg dose, 8.4% loss with 12mg of orforglipron, and 11.2% loss with 36mg of orforglipron, as compared with 2.1% loss with placebo (funded by Eli Lilly